MSD Korea announced urgent recall of Vioxx.

Published: 2004-10-07 06:43:00

Updated: 2004-10-07 06:43:00

MSD Korea instructed all physicians about an urgent recall of Vioxx via a phone or fax including official letters far aggressively for a prompt withdrawal of the stocks from the market place except wholesalers where prevailed its distribution, for which most of local wholesalers are in resentment...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK